Jul 27, 2013, 01.22 PM | Source: Moneycontrol.com
Rizatriptan Benzoate orally disintegrating tablets are a generic version of Merck's Maxalt MLT Tablets.
Glenmark Pharma 's US generics subsidiary and another generics drugs maker Natco Pharma have received final approval from US Food and Drug Administration for Rizatriptan Benzoate orally disintegrating tablets, used to treat migraine headaches.
Both the companies have approval to sell the tablets in 5mg and 10mg strengths.
Rizatriptan ODT is a generic version of Merck's Maxalt MLT tablets and Glenmark said it will start shipping its tablets immediately.
Natco said it has already started shipping the product launched by its marketing partner Breckenridge Pharmaceuticals.
Rizatriptan ODT had sales of USD 263 million for the year ended March 2013, Glenmark said, citing IMS Health data.
Glenmark now has 87 products authorized for distribution in the US market and 53 ANDAs (abbreviated new drug application) are pending approval with the drug regulator.
Glenmark shares ended up about 1 percent at Rs 575.35 on NSE on Tuesday. Natco ended up 1.5 percent at Rs 454.65.
Glenmark stock price
On February 11, 2016, Glenmark Pharma closed at Rs 720.05, down Rs 5.6, or 0.77 percent. The 52-week high of the share was Rs 1261.95 and the 52-week low was Rs 712.50.
The company's trailing 12-month (TTM) EPS was at Rs 57.81 per share as per the quarter ended December 2015. The stock's price-to-earnings (P/E) ratio was 12.46. The latest book value of the company is Rs 175.54 per share. At current value, the price-to-book value of the company is 4.10.
Bull's Eye: Buy Jet, Gati, IDFC Bank, UBL; sell Wockhardt
Gaurav Ratnaparkhi of Sharekhan advises buying Fed
Glenmark Q3 profit jumps 48% to Rs 170 cr
Glenmark Pharmaceuticals today reported 48.38 perc
Glenmark Q3 profit may surge 95%, US biz likely to pick up
Analysts feel US business is likely to pick up, ai
Glenmark Pharma gets USFDA nod for two generic drugs
"Glenmark Pharmaceuticals Inc has been granted fin
Buy Glenmark Pharma; like Lupin, Dr Reddy's Lab: Abhishek Sharma
Abhishek Sharma, Pharma Analyst at IIFL recommends
Buy UltraTech Cement, Titan Company: Kunal Bothra
Kunal Bothra of LKP Securities is of the view that
Why US tech giants are buying British AI start-ups
Microsoft announced that it had acquired London-ba
US, India in talks to settle solar power trade dispute
Washington filed the WTO challenge three years ago